The weight-loss drug Wegovy slashes the risk of heart disease even before people shed many pounds, data suggests.The drug, which contains the active ingredient semaglutide, works by reducing food ...

Vikrant Shrotriya said Human Mixtard is not being discontinued in India and will be supplied in vial presentation ...

The Tata-Cornell Institute project aims to strengthen Indian food value chains for climate resilience and nutritious diets.

Novonesis, a world-leading biosolutions company, co-hosted its 'Unlocking Value for a Sustainable Future' Partnering Day 2025 ...

Our writer can see the appeal of this recently popular dividend stock from the FTSE 100 index. But will he buy it for his own ...

The price of Wegovy, Novo Nordisk’s blockbuster weight-loss drug, is $1,349 a month in the U.S.; in Germany, it’s $328. The U.S. price for Keytruda, a cancer treatment, is $191,000 ...

Q1 2025 Management View Mike Exton, Chief Executive Officer, highlighted a pivotal exclusive license agreement with Novo Nordisk for LX9851, stating "this agreement grants Novo an exclusive worldwide ...

Novo Holdings, a global life sciences investor, today announced its investment in SCHOTT Poonawalla, India's leading provider ...

A pronouncement from President Trump about the category drove their share prices down, although not to bargain-basement ...

It's likely that Trump was referring to Elon Musk in the quoted tweet. Musk has publicly admitted to using weight-loss drugs ...

Analysts are still crunching the numbers on the impact of President Donald Trump's executive order from Monday on drug pricing. HSBC analyst Rajesh Kumar says a 20% price cut in government channels ...

Scientists herald 150 new jabs and pills to tackle obesity going through the research pipeline - but issue urgent warning to ...